- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03076528
An Innovative Virtually Supervised Exercise for Dialysis Patients
Among patients with diabetes 35% suffer from chronic renal disease and may require dialysis or kidney replacement over time. Furthermore, in diabetics with end stage renal disease (ESRD) that require dialysis, the risk of foot complications and amputation is even more common, expensive, and devastating. Interestingly, even though incidence of foot ulcers in patients with dialysis has been reported to be same as with patients with history of foot ulcers; dialysis patients have significantly higher rate of foot amputation.
The goal of this research is to incorporate an innovative virtually supervised non-weight bearing exercise in patients undergoing dialysis to reduce risk of fall and foot ulceration by enhancing lower extremity blood flow, joint perception and joint mobility.
Diabetic patients on hemodialysis at Hamad Medical Company will be recruited and will be randomized to either intervention (IG) or control (CG) group and followed for 6 months. The intervention group will take part in a 4-week non-weight bearing exercise program twice per week at the hemodialysis clinic under the supervision of a qualified research staff member. This intervention includes interactive game-based exercises including repetitive ankle and foot movements. Wearable sensors will provide real-time visual/auditory feedback from foot and ankle position and allowed perception of motor-errors during each motor-action. The control group will be instructed to complete a supervised foot and ankle exercise without using sensor technology. Changes in balance, gait, and physical activity, incidence of foot problems will be compared pre- and post-intervention. In addition, the incident of falls, foot ulcers, and limb amputation up to 6 months post intervention will be documented. Investigators hypothesize that patients receiving sensor-based exercises will benefit more compared to group receiving conventional non-technology training in terms of improving functional performance and reducing incidence of foot problems, falls, and limb amputation.
Study Overview
Status
Study Type
Enrollment (Anticipated)
Phase
- Phase 2
Contacts and Locations
Study Locations
-
-
-
Doha, Qatar
- Hamad Medical Coorporation
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Adults of 50 years or older, who are undergoing hemodialysis process
- Patients in diabetes
- Ability to provide consent
Exclusion Criteria:
- Non-ambulatory patients (unable to walk independently a distance of 20m with or without existence)
- Active foot ulcer
- Major foot amputation
- Charcot neuroarthropathy
- Major hearing/vision impaired
- Any patient with changes in psychotropic or sleep medications in the last 6 weeks
- Patients concurrently participating in another exercise training
- Patients with any clinically significant medical or psychiatric condition, or laboratory abnormality
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention with game-based exercise
Subjects will be receiving sensor-based interactive ankle & foot exercise program (game-based exercise) during hemo-dialysis, approximately 30 minutes, twice per week and for 4 weeks.
|
This intervention includes interactive game-based lower extremity training including repetitive ankle movements in multiple directions.
Wearable sensors will provide real-time feedback from foot and ankle position and allow perception of motor-errors during each motor-action
|
|
Active Comparator: Non-technology foot and ankle exercise program
Subjects will be receiving non-technology foot and ankle exercise program during hemodialysis, approximately 30 minutes, twice per week and for 4 weeks.
|
Subjects are asked to perform non-technology based foot and ankle exercises, which include plantar flexion and extension.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Gait Speed change from Baseline to 4 weeks
Time Frame: Baseline and 4 weeks
|
walking ability is quantified by gait speed
|
Baseline and 4 weeks
|
|
Balance change from Baseline to 4 weeks quantified by body sway
Time Frame: Baseline and 4 weeks
|
Balance is quantified by body sway
|
Baseline and 4 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Fear of Falling change from Baseline to 4 weeks using Fall Efficacy Scale International (FES-I) questionnaire
Time Frame: Baseline and 4 weeks
|
Measuring fear of falling using Fall Efficacy Scale International (FES-I) questionnaire
|
Baseline and 4 weeks
|
|
Depression change from Baseline to 4 weeks using Center of Epidemiologic Depression Scale (CES-D) questionnaire
Time Frame: Baseline to 4 weeks
|
Measuring depression using Center of Epidemiologic Depression Scale (CES-D) questionnaire
|
Baseline to 4 weeks
|
|
Change of Incident of falls
Time Frame: Baseline and 6 months
|
Baseline and 6 months
|
|
|
Change of Incidents of foot problems
Time Frame: Baseline and 6 months
|
Baseline and 6 months
|
Collaborators and Investigators
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- H-38522
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes
-
University of Colorado, DenverMassachusetts General Hospital; Beta Bionics, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Diabetes type1 | Type 1 Diabetes Mellitus | Autoimmune Diabetes | Diabetes Mellitus, Insulin-Dependent | Juvenile-Onset Diabetes | Diabetes, Autoimmune | Insulin-Dependent Diabetes Mellitus 1 | Diabetes Mellitus, Insulin-Dependent, 1 | Diabetes Mellitus, Brittle | Diabetes Mellitus, Juvenile-Onset and other conditionsUnited States
-
University of North Carolina, Chapel HillAmerican Diabetes AssociationNot yet recruitingType 2 Diabetes Mellitus (T2DM) | Diabetes (DM) | Insulin Dependent Diabetes | Type 1 Diabetes (T1D) | Diabetes Education | Diabetes Care | Diabetes (Insulin-requiring, Type 1 or Type 2)United States
-
Guang NingRecruitingType 2 Diabetes Mellitus | Type1 Diabetes Mellitus | Monogenetic Diabetes | Pancreatogenic Diabetes | Drug-Induced Diabetes Mellitus | Other Forms of Diabetes MellitusChina
-
University of North Carolina, Chapel HillAmerican Heart AssociationRecruitingType 2 Diabetes | Nutrition | Diabetes Type 2 | T2DM (Type 2 Diabetes Mellitus) | Diabetes Mellitis | T2DM | Diabetes EducationUnited States
-
University of Colorado, DenverMassachusetts General Hospital; Ann & Robert H Lurie Children's Hospital of... and other collaboratorsRecruitingDiabetes Mellitus | Diabetes | Type 2 Diabetes | Diabetes Mellitus Type 2 | Diabetes Mellitus, Type I | Diabetes Mellitus Type II | Diabetes Mellitus, Insulin-Dependent | Diabetes, Autoimmune | Type 1 Diabetes (T1D) | Diabetes Type 2 on Insulin | Diabetes, Type IIUnited States
-
University of Trás-os-Montes and Alto DouroCompletedType 2 Diabetes Mellitus | Diabetes-Related ComplicationsPortugal
-
Northern Care Alliance NHS Foundation TrustBrighter ABCompletedDiabetes type1 | Diabetes type2United Kingdom
-
Steno Diabetes Center CopenhagenNot yet recruitingDiabetes | Diabetes Type 1 | Diabetes Type 2 | Digital Health | Diabetes Care | Remote Patient MonitoringDenmark
-
VeraLight, Inc.InLight SolutionsUnknownGestational Diabetes | Insulin Dependent Diabetes | Non Insulin Dependent DiabetesUnited States
-
COUR Pharmaceutical Development Company, Inc.RecruitingType 1 Diabetes | Type 1 Diabetes Mellitus | T1DM | T1D | Type 1 Diabetes in Adolescence | Type 1 Diabetes in Children | Type 1 Diabetes Patients | Type 1 Diabetes Mellitis | T1DM - Type 1 Diabetes Mellitus | Type 1 Diabetes (Juvenile Onset)United States
Clinical Trials on Sensor-based interactive exercise (game-based exercise)
-
Baylor College of MedicineNational Institutes of Health (NIH)CompletedCancer | Chemotherapy Induced Peripheral NeuropathyUnited States
-
Taipei Medical University HospitalCompletedDiabetic Neuropathy Peripheral
-
Taipei Medical University HospitalCompleted
-
University of ArizonaUnknownStroke | Multiple Sclerosis | Diabetes | Cancer | Arthritis | Parkinson's Disease | Brain Injury | Cognitive DisordersUnited States
-
Baylor College of MedicineMedline IndustriesCompletedVenous Insufficiency of Leg | Lower Extremity Swelling | Lower Extremity EdemaUnited States
-
Istanbul Medipol University HospitalCompletedParkinson Disease | Exercise | Therapy | ExergameTurkey (Türkiye)
-
Uludag UniversityNot yet recruitingPain Management | Breathing Exercise | Non-Pharmacological Interventions | Venipuncture Pain
-
Anne KloosCompletedHuntington's DiseaseUnited States
-
National Taipei University of Nursing and Health...Active, not recruitingCognitive Function | Physical FunctionTaiwan
-
University of ArizonaUnknownKnee OsteoarthritisUnited States